Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VIEMED HEALTHCARE, INC.VMD · Entity 5824 | Director · Chief Operating Officer | January 29, 2026 | February 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VIEMED HEALTHCARE, INC.
Report date January 29, 2026 · Filed February 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 390,309 |
Ending reported balance
After 2026-01-29 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-01-29 · Exercise / conversion · Acquired 26,842 · Balance 401,677 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Row 2 · 2026-01-29 · Tax withholding · Disposed 11,368 · Balance 390,309 F2: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F3: Per share value is based on the market closing price of the common shares for January 29, 2026. Row 3 · 2026-01-29 · Exercise / conversion · Acquired 8,948 · Balance 399,257 F4: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Row 4 · 2026-01-29 · Disposition to issuer · Disposed 8,948 · Balance 390,309 F3: Per share value is based on the market closing price of the common shares for January 29, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-01-29 | Direct | 26,842 |
Reported balance
After 2026-01-29 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-01-29 · Exercise / conversion · Disposed 26,842 · Balance 26,842 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F5: Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date. |
| Phantom Share UnitsSEC Table II · derivative / convertible security · Expires 2027-01-29 | Direct | 8,946 |
Reported balance
After 2026-01-29 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-01-29 · Exercise / conversion · Disposed 8,948 · Balance 8,946 F4: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F6: Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F2: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F3: Per share value is based on the market closing price of the common shares for January 29, 2026.
F4: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F5: Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F6: Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 18, 2024 Filed Jan 22, 2024 22:36 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 18,979 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-24-000026 · wk-form4_1705962986.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| January 18, 2024 Filed Jan 26, 2024 20:16 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 5,761 | $7.62 | $43,898.82 |
DisclosureSEC source: 0001729149-24-000057 · wk-form4a_1706300197.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,884 F1 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F2 · shares: This filing amends the Form 4 originally filed on January 22, 2024, to correct an administrative error in reporting the number of shares withheld by the Company to satisfy the reporting person's tax obligation associated with the vesting of previously reported awards of restricted stock units. F3 · price: Per share value is based on the market closing price of the common shares for January 18, 2024. F4 · balance_after: Amounts beneficially owned have been adjusted to take into account the correction reported in footnote 2. Read SEC document |
| January 18, 2024 Filed Jan 26, 2024 20:14 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 9,490 | $7.62 | $72,313.80 |
DisclosureSEC source: 0001729149-24-000053 · wk-form4a_1706300049.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,666 F6 · price: Per share value is based on the market closing price of the common shares for January 18, 2024. F5 · balance_after: Amounts beneficially owned have been adjusted to take into account the correction reported in footnote 2. Read SEC document |
| January 18, 2024 Filed Jan 26, 2024 20:14 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 9,490 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-24-000053 · wk-form4a_1706300049.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F5 · balance_after: Amounts beneficially owned have been adjusted to take into account the correction reported in footnote 2. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 22:50 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 26,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-24-000012 · wk-form4_1705704620.xml · derivative · entry 8 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,878 Underlying: Common Shares · 26,940 shares Expires 2026-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F7 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 22:50 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 6,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-24-000012 · wk-form4_1705704620.xml · derivative · entry 7 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,470 Underlying: Common Shares · 6,735 shares Expires 2026-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F6 · derivative.exercise_date: Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 22:50 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 9,639 | $7.39 | $71,232.21 |
DisclosureSEC source: 0001729149-24-000012 · wk-form4_1705704620.xml · nonDerivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,252 F4 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F2 · price: Per share value is based on the market closing price of the common shares for January 17, 2024. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 22:50 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 26,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-24-000012 · wk-form4_1705704620.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 22:50 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 6,735 | $7.39 | $49,771.65 |
DisclosureSEC source: 0001729149-24-000012 · wk-form4_1705704620.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,951 F2 · price: Per share value is based on the market closing price of the common shares for January 17, 2024. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 22:50 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 6,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-24-000012 · wk-form4_1705704620.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,686 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 17, 2024 Filed Jan 26, 2024 20:14 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 9,225 | $7.39 | $68,172.75 |
DisclosureSEC source: 0001729149-24-000053 · wk-form4a_1706300049.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,666 F1 · shares: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. F2 · shares: This filing amends the Form 4 originally filed on January 19, 2024, to correct an administrative error in reporting the number of shares withheld by the Company to satisfy the reporting person's tax obligation associated with the vesting of previously reported awards of restricted stock units. F3 · price: Per share value is based on the market closing price of the common shares for January 17, 2024. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:35 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 3,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000083 · wf-form4_168383731491769.xml · derivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,251 Underlying: Common Shares · 3,251 shares Expires 2024-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F4 · derivative.exercise_date: Represents an award granted in 2021 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2023 and May 9, 2024, subject to the Reporting Person's continued employment with the Issuer on such vesting date. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:35 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 3,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000083 · wf-form4_168383731491769.xml · derivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,044 shares Expires 2023-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F3 · derivative.exercise_date: Represents an award granted in 2020 under the Issuer's Phantom Share Unit Plan which vested on May 9, 2023. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:35 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 3,251 | $10.50 | $34,119.25 |
DisclosureSEC source: 0001729149-23-000083 · wf-form4_168383731491769.xml · nonDerivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,951 Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:35 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 3,251 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-23-000083 · wf-form4_168383731491769.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:35 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 3,044 | $10.50 | $31,946.78 |
DisclosureSEC source: 0001729149-23-000083 · wf-form4_168383731491769.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,951 Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:35 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 3,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-23-000083 · wf-form4_168383731491769.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 00:01 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 18,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000017 · wf-form4_167408647693090.xml · derivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,958 Underlying: Common Shares · 18,979 shares Expires 2025-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F4 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 00:01 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 9,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000017 · wf-form4_167408647693090.xml · derivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,978 Underlying: Common Shares · 9,490 shares Expires 2025-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F3 · derivative.exercise_date: Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 00:01 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 18,979 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-23-000017 · wf-form4_167408647693090.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 00:01 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 9,490 | $7.77 | $73,737.30 |
DisclosureSEC source: 0001729149-23-000017 · wf-form4_167408647693090.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,739 Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 00:01 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 9,490 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-23-000017 · wf-form4_167408647693090.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:20 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionRestricted Stock Units · Derivative | 18,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000030 · wf-form4a_167425319048959.xml · derivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,958 Underlying: Common Shares · 18,979 shares Expires 2025-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F6 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:20 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 9,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000030 · wf-form4a_167425319048959.xml · derivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,978 Underlying: Common Shares · 9,490 shares Expires 2025-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. F5 · derivative.exercise_date: Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:20 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Tax withholdingCommon Shares | 6,767 | $7.77 | $52,579.59 |
DisclosureSEC source: 0001729149-23-000030 · wf-form4a_167425319048959.xml · nonDerivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,951 F4 · shares: On January 18, 2023, the reporting person filed a timely Form 4 which omitted the withholding of shares to satisfy tax obligations due to timing differences in the processing of awards. This amendment includes the timely reporting of tax related withholding of shares associated with vestings of awards previously reported on this form. F2 · price: Per share value is based on the market closing price of the common shares for January 18, 2023. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:20 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 18,979 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-23-000030 · wf-form4a_167425319048959.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:20 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 9,490 | $7.77 | $73,737.30 |
DisclosureSEC source: 0001729149-23-000030 · wf-form4a_167425319048959.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,739 F2 · price: Per share value is based on the market closing price of the common shares for January 18, 2023. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:20 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 9,490 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-23-000030 · wf-form4a_167425319048959.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 00:01 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantRestricted Stock Units · Derivative | 80,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000017 · wf-form4_167408647693090.xml · derivative · entry 7 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,818 Underlying: Common Shares · 80,818 shares Expires 2026-01-17 F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F7 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 00:01 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantPhantom Share Units · Derivative | 20,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000017 · wf-form4_167408647693090.xml · derivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,205 Underlying: Common Shares · 20,205 shares Expires 2026-01-17 F5 · derivative.exercise_price: Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F6 · derivative.exercise_date: Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2023 Filed Jan 20, 2023 22:20 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantRestricted Stock Units · Derivative | 80,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000030 · wf-form4a_167425319048959.xml · derivative · entry 8 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,818 Underlying: Common Shares · 80,818 shares Expires 2026-01-17 F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F9 · derivative.exercise_date: Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 17, 2023 Filed Jan 20, 2023 22:20 UTC Amendment | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantPhantom Share Units · Derivative | 20,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-23-000030 · wf-form4a_167425319048959.xml · derivative · entry 7 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,205 Underlying: Common Shares · 20,205 shares Expires 2026-01-17 F7 · derivative.exercise_price: Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F8 · derivative.exercise_date: Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:57 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 3,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-22-000050 · wf-form4_165221985559031.xml · derivative · entry 9 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,502 Underlying: Common Shares · 3,251 shares Expires 2024-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F5 · derivative.exercise_date: Represents an award granted in 2021 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2022, May 9, 2023, and May 9, 2024, subject to the Reporting Person's continued employment with the Issuer on such vesting date. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:57 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 3,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-22-000050 · wf-form4_165221985559031.xml · derivative · entry 8 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,044 Underlying: Common Shares · 3,044 shares Expires 2023-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F4 · derivative.exercise_date: Represents an award granted in 2020 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2022 and May 9, 2023, subject to the Reporting Person's continued employment with the Issuer on such vesting date. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:57 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 3,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-22-000050 · wf-form4_165221985559031.xml · derivative · entry 7 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,745 shares Expires 2022-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F3 · derivative.exercise_date: Represents an award granted in 2019 under the Issuer's Phantom Share Unit Plan which vests on May 9, 2022, subject to the Reporting Person's continued employment with the Issuer on such vesting date. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:57 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 3,251 | $5.26 | $17,100.26 |
DisclosureSEC source: 0001729149-22-000050 · wf-form4_165221985559031.xml · nonDerivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,739 Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:57 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 3,251 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-22-000050 · wf-form4_165221985559031.xml · nonDerivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:57 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 3,044 | $5.26 | $16,011.44 |
DisclosureSEC source: 0001729149-22-000050 · wf-form4_165221985559031.xml · nonDerivative · entry 4 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,739 Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:57 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 3,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-22-000050 · wf-form4_165221985559031.xml · nonDerivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:57 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 3,745 | $5.26 | $19,698.70 |
DisclosureSEC source: 0001729149-22-000050 · wf-form4_165221985559031.xml · nonDerivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,739 Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:57 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 3,745 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-22-000050 · wf-form4_165221985559031.xml · nonDerivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:32 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantPhantom Share Units · Derivative | 28,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-22-000012 · wf-form4_164271792306457.xml · derivative · entry 3 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,468 Underlying: Common Shares · 28,468 shares Expires 2025-01-18 F4 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F5 · derivative.exercise_date: Represents an award granted in 2022 under the Issuer's Phantom Share Unit Plan which vests in equal installments on January 18, 2023, January 18, 2024, and January 18, 2025, subject to the Reporting Person's continued employment with the Issuer on such vesting date. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:32 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantRestricted Stock Units · Derivative | 56,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-22-000012 · wf-form4_164271792306457.xml · derivative · entry 2 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,937 Underlying: Common Shares · 56,937 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F3 · derivative.exercise_date: Restricted Stock Units granted to reporting person on January 18, 2022, which vest in three equal installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: Restricted Stock Units granted to reporting person on January 18, 2022, which vest in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:32 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantStock Options · Derivative | 85,410 | $0.00 Strike: $5.21 | $0.00 |
DisclosureSEC source: 0001729149-22-000012 · wf-form4_164271792306457.xml · derivative · entry 1 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,410 Underlying: Common Shares · 85,410 shares Expires 2032-01-18 F1 · derivative.exercise_date: Options granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| May 09, 2021 Filed May 10, 2021 20:24 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 3,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-21-000090 · wf-form4_162067827588732.xml · derivative · entry 10 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,088 Underlying: Common Shares · 3,044 shares Expires 2023-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F6 · derivative.exercise_date: Represents an award granted in 2020 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2021, May 9, 2022, and May 9, 2023, subject to the Reporting Person's continued employment with the Issuer on such vesting date. Read SEC document |
| May 09, 2021 Filed May 10, 2021 20:24 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 3,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-21-000090 · wf-form4_162067827588732.xml · derivative · entry 9 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,745 Underlying: Common Shares · 3,745 shares Expires 2022-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F5 · derivative.exercise_date: Represents an award granted in 2019 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2021 and May 9, 2022, subject to the Reporting Person's continued employment with the Issuer on such vesting date. Read SEC document |
| May 09, 2021 Filed May 10, 2021 20:24 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionPhantom Share Units · Derivative | 56,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-21-000090 · wf-form4_162067827588732.xml · derivative · entry 8 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 56,475 shares Expires 2021-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F4 · derivative.exercise_date: Represents an award granted in 2018 under the Issuer's Phantom Share Unit Plan which vests on May 9, 2021, subject to the Reporting Person's continued employment with the Issuer on such vesting date. Read SEC document |
| May 09, 2021 Filed May 10, 2021 20:24 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | GrantPhantom Share Units · Derivative | 9,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001729149-21-000090 · wf-form4_162067827588732.xml · derivative · entry 7 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,753 Underlying: Common Shares · 9,753 shares Expires 2024-05-09 F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. F3 · derivative.exercise_date: Represents an award granted in 2021 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2022, May 9, 2023, and May 9, 2024, subject to the Reporting Person's continued employment with the Issuer on such vesting date. Read SEC document |
| May 09, 2021 Filed May 10, 2021 20:24 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 3,044 | $9.57 | $29,131.08 |
DisclosureSEC source: 0001729149-21-000090 · wf-form4_162067827588732.xml · nonDerivative · entry 6 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,739 Read SEC document |
| May 09, 2021 Filed May 10, 2021 20:24 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 3,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-21-000090 · wf-form4_162067827588732.xml · nonDerivative · entry 5 ZEHNDER WILLIAM TODD · CIK 0001429216 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.